Opportunity Information: Apply for PA 13 261
Apply for PA 13 261
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Secondary Analyses of Alcohol and Chronic Disease (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273 Alcohol Research Programs.
- This funding opportunity was created on Jul 8, 2013 and posted on Jul 8, 2013.
- Applicants must submit their applications by Sep 7, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: Native American tribal governments (Federally recognized) City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Independent school districts For profit organizations other than small businesses State governments Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Public housing authorities/Indian housing authorities Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The NIH grant opportunity titled "Secondary Analyses of Alcohol and Chronic Disease (R03)" (Funding Opportunity Number PA 13-261) was a discretionary research grant program designed to support small, targeted projects that use existing data to study how alcohol relates to chronic disease. Rather than funding new data collection, the announcement focused on secondary analyses, meaning applicants were expected to take advantage of previously collected datasets (for example, established cohort studies, surveillance data, clinical trial datasets, electronic health records, or other archived research resources) to answer new or refined questions about alcohol exposure and chronic disease outcomes. The central purpose was to encourage innovative, efficient, and cost-effective research that could advance understanding of chronic disease etiology and epidemiology in relation to alcohol use, without the time and expense of launching new primary studies.
The mechanism for this opportunity was the NIH R03, which is a small grant mechanism typically used for pilot work, feasibility studies, or discrete, well-scoped projects. Consistent with that structure, the program listed an award ceiling of $50,000, emphasizing modest budgets and focused aims. No cost sharing or matching was required, which generally lowers barriers for applicants and allows institutions to propose work based on scientific merit and feasibility rather than access to non-federal matching funds. The activity category was Health, and the program aligned with CFDA number 93.273 (Alcohol Research Programs), placing it within NIH's alcohol-related research portfolio.
In practical terms, competitive applications under this FOA would likely have proposed rigorous analytic approaches to examine relationships between alcohol consumption patterns (such as quantity, frequency, binge drinking, age of initiation, duration of use, or changes over time) and chronic disease endpoints (such as cardiovascular disease, cancer, liver disease, diabetes, neurocognitive decline, or other long-term health outcomes). Because this was an epidemiology- and etiology-oriented call, projects would typically be expected to address issues like confounding, effect modification, dose-response relationships, measurement quality of alcohol exposure, subgroup differences, and the timing of exposure relative to disease development. The emphasis on secondary analysis also implies that strong proposals would demonstrate that the existing dataset is well-suited to the research question, that key variables are available and valid, and that the analytic plan can be executed within the limited R03 scope and budget.
Eligibility was broad and included many types of U.S. and non-U.S. organizations. Domestic eligible applicants included federal, state, county, city/township, and special district governments; public and private institutions of higher education; independent school districts; small businesses and other for-profit organizations (other than small businesses were also listed); public housing authorities/Indian housing authorities; and nonprofit organizations both with and without 501(c)(3) status (excluding higher education institutions in those nonprofit categories as specified). The FOA also explicitly included a wide range of mission- or population-focused institutions and organizations, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with tribal governments (federally recognized and other than federally recognized) and tribal organizations. Faith-based and community-based organizations were also included. Importantly, the opportunity allowed foreign participation: non-U.S. entities (foreign organizations and foreign institutions) were eligible to apply, non-U.S. components of U.S. organizations could participate, and foreign components were allowed as defined by the NIH Grants Policy Statement. This international openness fits well with secondary analysis work, where valuable datasets may originate from outside the United States or involve multinational collaborations.
From an administrative timeline standpoint, the opportunity was posted on July 8, 2013, with an original closing date of September 7, 2016, and a current closing date also listed as September 7, 2016. The archive date was October 8, 2016, meaning the announcement is no longer active for submission under that specific FOA. The sponsoring agency was the National Institutes of Health, and the full archived announcement was available through the NIH Grants Guide at the provided link (http://grants.nih.gov/grants/guide/pa-files/PA-13-261.html). For access issues, the contact point listed was the NIH Office of Extramural Research (OER) Webmaster (FBOWebmaster@OD.NIH.GOV), which is primarily a technical contact for difficulties reaching the announcement rather than a scientific/program contact for application content.
Overall, PA 13-261 was aimed at generating publishable, policy-relevant, or clinically meaningful insights by extracting more value from existing data resources, specifically to clarify the role of alcohol in chronic disease development and population health patterns. It targeted studies that could move the field forward efficiently by asking sharper questions, applying improved analytic methods, or exploring understudied subgroups or outcomes, all within the constrained, focused format of an R03 small grant.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this NIH grant?
The opportunity is titled "Secondary Analyses of Alcohol and Chronic Disease (R03)" and the Funding Opportunity Number is PA 13-261.
What was the main purpose of PA 13-261?
The program was designed to support small, targeted research projects that use existing data to study how alcohol exposure relates to chronic disease outcomes. The goal was to promote innovative, efficient, and cost-effective research that could advance understanding of chronic disease etiology and epidemiology without starting new primary data collection.
What type of grant mechanism was used?
This opportunity used the NIH R03 mechanism, which is a small grant format typically suited for pilot work, feasibility studies, or discrete, well-scoped projects.
What was the award ceiling for this R03 opportunity?
The program listed an award ceiling of $50,000, reflecting the expectation of modest budgets and focused aims consistent with an R03 project.
Was cost sharing or matching required?
No. The announcement specified that no cost sharing or matching was required.
What kinds of research activities were encouraged?
The FOA emphasized secondary analyses examining relationships between alcohol consumption patterns and chronic disease endpoints. Competitive applications would typically propose rigorous analytic approaches to address questions about etiology and epidemiology using existing datasets.
Did the FOA support new data collection?
No. The announcement focused on secondary analyses, meaning applicants were expected to use previously collected data rather than collecting new primary data for the project.
What does "secondary analysis" mean in this context?
Secondary analysis refers to analyzing data that were already collected for another purpose (for example, cohort studies, surveillance systems, clinical trial datasets, electronic health records, or other archived research resources) to answer new or refined research questions about alcohol exposure and chronic disease outcomes.
What types of datasets were considered relevant for this opportunity?
Examples mentioned include established cohort studies, surveillance data, clinical trial datasets, electronic health records, and other archived research resources, as long as they contain suitable measures of alcohol exposure and chronic disease outcomes for the proposed analyses.
What alcohol exposure patterns were considered in scope?
The FOA highlighted analyses of alcohol consumption patterns such as quantity, frequency, binge drinking, age of initiation, duration of use, and changes in use over time.
What chronic disease outcomes were considered in scope?
Examples listed include cardiovascular disease, cancer, liver disease, diabetes, neurocognitive decline, and other long-term health outcomes.
What analytic or epidemiologic issues were applicants expected to address?
Because the call was oriented toward epidemiology and etiology, projects would typically be expected to address issues such as confounding, effect modification, dose-response relationships, measurement quality of alcohol exposure, subgroup differences, and the timing of exposure relative to disease development.
What would make an existing dataset "well-suited" to a proposed project?
The FOA implied that strong applications would show that key variables are available and valid, that the dataset can answer the proposed questions, and that the analytic plan can be completed within the limited scope and budget of an R03.
What was the activity category and CFDA number associated with this opportunity?
The activity category was Health, and the program aligned with CFDA number 93.273 (Alcohol Research Programs).
Who was eligible to apply (in general terms)?
Eligibility was broad and included many types of U.S. and non-U.S. organizations, spanning government entities, higher education institutions, nonprofits, and for-profit organizations.
Which U.S. government entities were eligible?
Domestic eligible applicants included federal, state, county, city/township, and special district governments.
Were universities and colleges eligible to apply?
Yes. Public and private institutions of higher education were included among eligible applicants.
Were nonprofit organizations eligible to apply?
Yes. Nonprofit organizations with and without 501(c)(3) status were included (with the nonprofit categories described as excluding higher education institutions as specified in the FOA language).
Were for-profit organizations eligible to apply?
Yes. Small businesses and other for-profit organizations (with "other than small businesses" also listed) were included among eligible applicants.
Were school districts eligible to apply?
Yes. Independent school districts were listed as eligible applicants.
Were housing authorities eligible to apply?
Yes. Public housing authorities/Indian housing authorities were listed as eligible applicants.
Were tribal governments and tribal organizations eligible?
Yes. The FOA included tribal governments (federally recognized and other than federally recognized) and tribal organizations.
Did the FOA include specific institution types such as HBCUs and Hispanic-serving institutions?
Yes. The eligibility language explicitly included HBCUs, Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Were faith-based and community-based organizations eligible?
Yes. Faith-based and community-based organizations were explicitly included.
Was foreign participation allowed?
Yes. Non-U.S. entities (foreign organizations and foreign institutions) were eligible to apply. In addition, non-U.S. components of U.S. organizations could participate, and foreign components were allowed as defined by the NIH Grants Policy Statement.
When was the opportunity posted, and what were the closing and archive dates?
The opportunity was posted on July 8, 2013. The original closing date and the listed current closing date were both September 7, 2016. The archive date was October 8, 2016.
Is PA 13-261 still active for submissions?
No. The announcement is archived (archive date October 8, 2016) and is no longer active for submission under that specific FOA.
Which agency sponsored this funding opportunity?
The sponsoring agency was the National Institutes of Health (NIH).
Where could applicants find the full archived announcement?
The archived announcement was available through the NIH Grants Guide at: http://grants.nih.gov/grants/guide/pa-files/PA-13-261.html
Who was listed as the contact for access issues with the announcement?
The contact point listed for access issues was the NIH Office of Extramural Research (OER) Webmaster at FBOWebmaster@OD.NIH.GOV.
Was the listed contact a scientific or program contact for application content?
No. The listed contact was described as primarily a technical contact for difficulties reaching the announcement rather than a scientific or program contact for application content.
What kinds of results was this FOA trying to generate?
Overall, the FOA aimed to generate publishable, policy-relevant, or clinically meaningful insights by extracting more value from existing data resources to clarify the role of alcohol in chronic disease development and population health patterns.
How did the R03 format shape the kinds of projects expected under this FOA?
Because the mechanism was an R03 with a modest award ceiling, the FOA implicitly favored discrete, sharply defined aims and analysis plans that could be completed efficiently using existing datasets, without the time and expense of launching new studies.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Health
Next opportunity: Dose Response and Efficacy Studies on the Effects of Vitamin D Supplementation on Functional Outcomes in Elderly (U01)
Previous opportunity: Secondary Analyses of Alcohol and Chronic Disease (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 261
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 261) also looked into and applied for these:
| Funding Opportunity |
|---|
| Dose Response and Efficacy Studies on the Effects of Vitamin D Supplementation on Functional Outcomes in Elderly (U01) Apply for RFA AG 14 001 Funding Number: RFA AG 14 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Implications of New Digital Media Use for Underage Drinking, Drinking Related Behaviors, and Prevention Research (R21) Apply for PA 13 263 Funding Number: PA 13 263 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Implications of New Digital Media Use for Underage Drinking, Drinking Related Behaviors, and Prevention Research (R01) Apply for PA 13 262 Funding Number: PA 13 262 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Novel NeuroAIDS Therapeutics Integrated Preclinical/Clinical Program (P01) Apply for PAR 13 267 Funding Number: PAR 13 267 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Developing a Point of Care Device for the Diagnosis of Sickle Cell Disease in Low Resource Settings SBIR (R43/ R44) Apply for RFA HL 14 010 Funding Number: RFA HL 14 010 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| NEI Center Core Grants for Vision Research (P30) Apply for PAR 13 269 Funding Number: PAR 13 269 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health Promotion and Disease Prevention Research Centers Apply for RFA DP 14 001 Funding Number: RFA DP 14 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $900,000 |
| Urban Indian Education and Research Organization Cooperative Agreement Program Apply for HHS 2013 IHS OUIHP 0001 Funding Number: HHS 2013 IHS OUIHP 0001 Agency: Indian Health Service Category: Health Funding Amount: $800,000 |
| NINDS Clinical Trial Methods in Clinical Neurological Disorders Course (R25) Apply for RFA NS 14 001 Funding Number: RFA NS 14 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Researcher Training and Workforce Development in Methods and Standards for Conducting Patient Centered Outcomes Research Studies (R25) Apply for RFA HS 14 004 Funding Number: RFA HS 14 004 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Instrument Development for Biomedical Applications (R21) Apply for RFA GM 14 014 Funding Number: RFA GM 14 014 Agency: National Institutes of Health Category: Health Funding Amount: $175,000 |
| Mentored Research Scientist Development Award (K01) Apply for PAR 13 245 Funding Number: PAR 13 245 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $100,000 |
| Affordable Care Act Maternal, Infant and Early Childhood Home Visiting Formula Grant Program Apply for HRSA 13 278 Funding Number: HRSA 13 278 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Blood Pressure Measurement Technologies for Low Resource Settings in the U.S. and India (U01) Apply for RFA EB 13 001 Funding Number: RFA EB 13 001 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Emerging Priorities in Reproductive, Maternal and Newborn Health Apply for APS OAA 13 000005 Funding Number: APS OAA 13 000005 Agency: Agency for International Development Category: Health Funding Amount: $9,000,000 |
| National Center for Construction Safety and Health Research and Translation (U60) Apply for RFA OH 13 001 Funding Number: RFA OH 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,750,000 |
| Clinical Trial of a Multifactorial Fall Injury Prevention Strategy in Older Persons (U01) Apply for RFA AG 14 009 Funding Number: RFA AG 14 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mid life Reversibility of Early established Biobehavioral Risk Factors (R01) Apply for RFA AG 14 006 Funding Number: RFA AG 14 006 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| High Priority Behavioral and Social Research Networks (R24) Apply for RFA AG 14 007 Funding Number: RFA AG 14 007 Agency: National Institutes of Health Category: Health Funding Amount: $175,000 |
| FY 2013 Program Supplement for MAI TCE Program Enhancement of HIV Care and Outcomes through Screening for Substance Use and Mental Disorders Apply for SM 13 013 Funding Number: SM 13 013 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 261", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.